Therapeutic use of Rituximab for sinus histiocytosis with massive lymphadenopathy (Rosai‐Dorfman disease)
Authors:
Open Access
- 1 November 2007
- journal article
- letter
- Published by Wiley in American Journal of Hematology
- Vol. 82 (12) , 1121-1122
Abstract
No abstract availableKeywords
This publication has 4 references indexed in Scilit:
- Histologic Features of Sinus Histiocytosis With Massive Lymphadenopathy in Patients With Autoimmune Lymphoproliferative SyndromeAmerican Journal of Surgical Pathology, 2005
- Characterization of clonogenic multiple myeloma cellsBlood, 2004
- Treatment of sinus histiocytosis with massive lymphadenopathy (rosai‐dorfman disease): Report of a case and literature reviewAmerican Journal of Hematology, 2001
- »Katastrophaler SLE« mit Rosai-Dorfman-SinushistiozytoseDMW - Deutsche Medizinische Wochenschrift, 2001